Desjardins, A., Randazzo, D., Chandramohan, V., Peters, K., Johnson, M., Landi, D., … Bigner, D. (2020). A PHASE 1 TRIAL OF D2C7-IT IN COMBINATION WITH ATEZOLIZUMAB IN RECURRENT WHO GRADE IV MALIGNANT GLIOMA (MG). In NEURO-ONCOLOGY (Vol. 22, pp. 38–38).

Desjardins, Annick, Dina Randazzo, Vidya Chandramohan, Katherine Peters, Margaret Johnson, Daniel Landi, Mustafa Khasraw, et al. “A PHASE 1 TRIAL OF D2C7-IT IN COMBINATION WITH ATEZOLIZUMAB IN RECURRENT WHO GRADE IV MALIGNANT GLIOMA (MG).” In NEURO-ONCOLOGY, 22:38–38, 2020.

Desjardins A, Randazzo D, Chandramohan V, Peters K, Johnson M, Landi D, et al. A PHASE 1 TRIAL OF D2C7-IT IN COMBINATION WITH ATEZOLIZUMAB IN RECURRENT WHO GRADE IV MALIGNANT GLIOMA (MG). In: NEURO-ONCOLOGY. 2020. p. 38–38.

Desjardins, Annick, et al. “A PHASE 1 TRIAL OF D2C7-IT IN COMBINATION WITH ATEZOLIZUMAB IN RECURRENT WHO GRADE IV MALIGNANT GLIOMA (MG).” NEURO-ONCOLOGY, vol. 22, 2020, pp. 38–38.

Desjardins A, Randazzo D, Chandramohan V, Peters K, Johnson M, Landi D, Khasraw M, Threatt S, Bullock C, Herndon JII, Lipp E, Sampson J, Friedman A, Friedman H, Ashley D, Bigner D. A PHASE 1 TRIAL OF D2C7-IT IN COMBINATION WITH ATEZOLIZUMAB IN RECURRENT WHO GRADE IV MALIGNANT GLIOMA (MG). NEURO-ONCOLOGY. 2020. p. 38–38.